The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s cardiac valve market report forecasts the cardiac valve market size to grow to $15.39 Billion by 2027, with a CAGR (compound annual growth rate) of more than 12%.

Learn More On The Cardiac Valve Market Report 2023 – https://www.thebusinessresearchcompany.com/report/cardiac-valve-global-market-report

Cardiac Valve Market Size Forecast
The global cardiac valve market is expected to grow from $8.35 billion in 2022 to $9.51 billion in 2023 at a compound annual growth rate (CAGR) of 13.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The cardiac valve market size is expected to grow to $15.39 billion in 2027 at a CAGR of 12.8%.

North America held the largest cardiac valve market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Cardiac Valve Market Driver ­– Rise In The Incidence Of Cardiovascular Diseases
According to the Center for Disease Control and prevention, an American national public health agency, approximately 697,000 people in the US died from heart disease in 2020, which converted to almost 1 in 5 deaths. Therefore, the rising incidence of cardiovascular diseases will drive the cardiac valve market.

Request for A Sample Of The Global Cardiac Valve Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7753&type=smp

Key Cardiac Valve Market Trend – Technological Advancement
With advancements in technology, there are less invasive treatment options for heart diseases. Major companies operating in the cardiac valve market are concentrating on technologies such as neochordae implantation, annuloplasty ring, and robotic surgery to strengthen their market position. These innovative technologies help to protect patients from life-threatening conditions such as heart stroke and cardiac arrest. For instance, in July 2020, LivaNova PLC, a UK- based cardiac surgery and neuromodulation device manufacturing company, launched Perceval Plus sutureless surgical aortic heart valve based on sutureless surgical technology. This sutureless technology offers minimally invasive heart surgery with anti-calcification treatment with long durability. Furthermore, in September 2020, Boston Scientific Corporation, a US-based medical technology company, launched transcatheter aortic valve implantation (TAVI) technology. This technology is used for aortic stenosis treatment by lowering mortality, complications, and surgical cost for the treatment of heart diseases.

Cardiac Valve Market Segment
1) By Type: Tissue Heart Valves, Transcatheter Heart Valves, Mechanical Heart Valves, Other Types
2) By Position: Aortic Valve, Mitral Valve, Other Positions
3) By Treatment: Cardiac Valve Repair, Cardiac Valve Replacement
4) By End-Users: Hospital And Clinics, Specialty Centers, Cardiac Research Institute, Other End Users

Cardiac Valve Market Major Players and Strategies
Major players in the cardiac valve market are LivaNova PLC, Abbott Laboratories, Colibri Heart Valve LLC, TTK HealthCare Limited, Artivion Inc., JenaValve Technology Inc., Edwards Lifesciences Corporation, Lepu Medical Technology Co., Ltd., Braile Biomédica, Foldax Inc., Sorin SpA, Neovasc Inc., The RUA Life Sciences group, Translumina Therapeutics Private Limited, and On-X Life Technologies.

In January 2022, Venus Medtech, the China-based structural heart disease treatment company, acquired Cardiovalve Ltd. for an undisclosed amount. With this acquisition, Venus Medtech will continue progressing clinical research in Europe and the United States while accelerating clinical development and commercialization in China. This acquisition would allow Venus Medtech to become China’s most comprehensive platform for treating mitral and tricuspid regurgitation. Cardiovalve Ltd. is an Israel-based medical device company developing a transfemoral mitral valve replacement system.

The Cardiac Valve Global Market Report 2023 covers regional data on cardiac valve market size, cardiac valve market trends and drivers, opportunities, strategies, and cardiac valve market competitor analysis. The countries covered in the cardiac valve market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Cardiac valves refer to artificial valves used to keep the flow of blood in one direction from the heart to the rest of the body parts. A cardiac valve is an implantable device used to replace a damaged body valve that has stopped working due to various diseases. The primary function of the cardiac valve is to keep blood flowing in the proper direction through the heart and from the heart into the major blood vessels connected to it.

View More Reports Related To The Cardiac Valve Market –
Cardiac Pacemakers Global Market Report 2023
Cardiac Assist Devices And Equipment Global Market Report 2023
Cardiovascular Devices Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: